COVID-19 (SARS-CoV-2 infection) Infections and Infestations
Conditions
Interventions
The evaluation will review the effectiveness of a 12-week community rehabilitation programme on improvements in quality of life and reductions in symptoms of COVID-19, in individuals recovering from t
Sponsors
Nuffield Health
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Previous confirmed diagnosis of COVID-19 2. Able to walk independently for a minimum of 20 meters 3. Must have access to the internet and smartphone/tablet/personal computer (with adequate technological literacy) 4. Over 18 years of age 5. Access to transport to attend rehabilitation
Exclusion criteria
Exclusion criteria: 1. Have active COVID-19 symptoms 2. Are already receiving community rehabilitation 3. Have un-managed medical conditions that contraindicate unsupervised exercise 4. Have a formal diagnosis of post-traumatic stress syndrome, clinically significant anxiety or depression where low-intensity mental health intervention will not assist 5. Have been diagnosed with Chronic Fatigue Syndrome
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of life measured using EuroQoL Five Dimension Five Level Version (EQ-5D-5 L) at baseline, 6 and 12 weeks and 6 and 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Symptoms relating to COVID-19 measured using Dyspnea-12 at baseline, 6 and 12 weeks and 6 and 12 months 2. Functional capacity measured by The Duke Activity Status Index (DASI) at baseline, 6 and 12 weeks and 6 and 12 months 3. Patient strength and endurance measured using the 30-second sit to stand test at baseline, 6 and 12 weeks and 6 and 12 months 4. General anxiety measured using General Anxiety Disorder-7 at baseline, 12 weeks and 6 and 12 months | — |
Countries
England, United Kingdom
Contacts
Public ContactBenjamin Kelly
Outcome results
None listed